Vitamin B6 and cancer: From clinical data to molecularly mechanisms;Vitamine B6 et cancer: Des données cliniques aux mécanismes moléculaires

Bulletin du Cancer

Volumn 98, Issue 10, 2011, Pages 1201-1208

  Sujol, Guillaume ^a,b,c   Docquier, Aurélie ^a,b,c   Boulahtouf, Abdelhay ^a,b,c   Castet Nicolas, Audrey ^a,b,c,d   Cavaillès, Vincent ^a,b,c  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

^c CENTRE VAL D AURELLE   (France)

^d LAPEYRONIE HOSPITAL   (France)

Author keywords

Cancer; Epigenetics; Gene expression; Post translational modification; Transcription; Vitamin B6

Indexed keywords

PYRIDOXINE; RECEPTOR INTERACTING PROTEIN 140; CELL RECEPTOR; HISTONE; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER HORMONE THERAPY; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; COLORECTAL CANCER; CONJUGATION; DNA METHYLATION; ENZYME MECHANISM; HISTONE METHYLATION; HUMAN; IMMUNE RESPONSE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVIEW; RISK REDUCTION; TRANSACTIVATION; VITAMIN BLOOD LEVEL; ANIMAL; COLORECTAL TUMOR; GENETIC EPIGENESIS; METABOLISM; NEOPLASM; PHYSIOLOGY; RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; COLORECTAL NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VITAMIN B 6;

EID: 80755175263     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1458     Document Type: Review

References (47)

1. Milner JA. Nutrition and cancer: essential elements for a roadmap. Cancer Lett 2008; 269 : 189-98.
2. Yeh JK, Brown RR. Effects of vitamin B-6 deficiency and tryptophan loading on urinary excretion of tryptophan metabolites in mammals. J Nutr 1977; 107 : 261-71. (Pubitemid 8042083)
3. Percudani R, Peracchi A. The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein families. BMC Bioinformatics 2009; 10 : 273.
4. Morris MS, Sakakeeny L, Jacques PF, Picciano MF, Selhub J. Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status. J Nutr 2010; 140 : 103-10.
5. Yanaka N, Ohata T, Toya K, Kanda M, Hirata A, Kato N. Vitamin B6 suppresses serine protease inhibitor 3 expression in the colon of rats and in TNF-alpha-stimulated HT-29 cells. Mol Nutr Food Res 2011; 55 : 635-43.
6. Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 2010; 303 : 1077-83.
7. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002; 13 : 239-48. (Pubitemid 34438233)
8. Le Marchand L, White KK, Nomura AM, et al. Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18 : 2195-201.
9. Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 2005; 97 : 684-92. (Pubitemid 40812632)
10. Martinez ME, Henning SM, Alberts DS. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr 2004; 79 : 691-7. (Pubitemid 41103916)
11. Lajous M, Romieu I, Sabia S, Boutron-Ruault MC, Clavel-Chapelon F. Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women. Cancer Causes Control 2006; 17 : 1209-13. (Pubitemid 44470410)
12. Lajous M, Lazcano-Ponce E, Hernandez-Avila M, Willett W, Romieu I. Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 2006; 15 : 443-8.
13. Levi F, Pasche C, Lucchini F, La Vecchia C. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 2001; 91 : 260-3. (Pubitemid 32041750)
14. Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003; 95 : 373-80. (Pubitemid 36395257)
15. Hartman TJ, Woodson K, Stolzenberg-Solomon R, et al. Association of the B-vitamins pyridoxal 5′-phosphate (B(6)), B(12), and folate with lung cancer risk in older men. Am J Epidemiol 2001; 153 : 688-94. (Pubitemid 32250977)
16. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999; 91 : 535-41. (Pubitemid 29157062)
17. Schernhammer E, Wolpin B, Rifai N, et al. Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res 2007; 67 : 5553-60. (Pubitemid 46997298)
18. Kotsopoulos J, Hecht JL, Marotti JD, Kelemen LE, Tworoger SS. Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor alpha expression in ovarian tumors. Int J Cancer 2010; 126 : 2191-8.
19. Kasperzyk JL, Fall K, Mucci LA, et al. One-carbon metabolism-related nutrients and prostate cancer survival. Am J Clin Nutr 2009; 90 : 561-9.
20. Komatsu SI, Watanabe H, Oka T, Tsuge H, Nii H, Kato N. Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr 2001; 131 : 2204-7. (Pubitemid 32720653)
21. Gridley DS, Stickney DR, Nutter RL, Slater JM, Shultz TD. Suppression of tumor growth and enhancement of immune status with high levels of dietary vitamin B6 in BALB/c mice. J Natl Cancer Inst 1987; 78 : 951-9. (Pubitemid 17093021)
22. Jain SK, Lim G. Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na++ K+)-ATPase activity reduction in high glucose-treated human erythrocytes. Free Radic Biol Med 2001; 30 : 232-7. (Pubitemid 32126443)
23. Komatsu S, Watanabe H, Oka T, Tsuge H, Kat N. Dietary vitamin B6 suppresses colon tumorigenesis, 8-hydroxyguanosine, 4-hydroxynonenal, and inducible nitric oxide synthase protein in azoxymethane-treated mice. J Nutr Sci Vitaminol (Tokyo) 2002; 48 : 65-8. (Pubitemid 34288926)
24. Martial J, Zaldivar J, Bull P, Venegas A, Valenzuela P. Inactivation of rat liver RNA polymerases I and II and yeast RNA polymerase I by pyrodixal 5′-phosphate. Evidence for the participation of lysyl residues at the active site. Biochemistry 1975; 14 : 4907-11.
25. Matsubara K, Matsumoto H, Mizushina Y, Lee JS, Kato N. Inhibitory effect of pyridoxal 5′-phosphate on endothelial cell proliferation, replicative DNA polymerase and DNA topoisomerase. Int J Mol Med 2003; 12 : 51-5.
26. Ren SG, Melmed S. Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion. Endocrinology 2006; 147 : 3936-42. (Pubitemid 44079399)
27. Matsubara K, Mori M, Akagi R, Kato N. Anti-angiogenic effect of pyridoxal 5′-phosphate, pyridoxal and pyridoxamine on embryoid bodies derived from mouse embryonic stem cells. Int J Mol Med 2004; 14 : 819-23.
28. Oka T, Sugitatsu H, Nordin H, et al. Pyridoxal 5′-phosphate inhibits DNA binding of HNF1. Biochim Biophys Acta 2001; 1568 : 189-96. (Pubitemid 34107293)
29. Allgood VE, Cidlowski JA. Vitamin B6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily. J Biol Chem 1992; 267 : 3819-24.
30. D'Errico I, Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci 2008; 65 : 1523-43.
31. Huq MD, Tsai NP, Lin YP, Higgins L, Wei LN. Vitamin B6 conjugation to nuclear corepressor RIP140 and its role in gene regulation. Nat Chem Biol 2007; 3 : 161-5.
32. Augereau P, Badia E, Carascossa S, et al. The nuclear receptor transcriptional coregulator RIP140. Nucl Recept Signal 2006 ; 4 : e024.
33. Docquier A, Harmand PO, Fritsch S, Chanrion M, Darbon JM, Cavailles V. The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypes. Clin Cancer Res 2010; 16 : 2959-70.
34. Zschiedrich I, Hardeland U, Krones-Herzig A, et al. Co-activator function of RIP140 for NF{kappa}B/RelA-dependent cytokine gene expression. Blood 2008; 112 : 264-6.
35. Fritah A, Christian M, Parker MG. The metabolic coregulator RIP140: an update. Am J Physiol Endocrinol Metab 2010; 299 : E335-40.
36. Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358 : 1148-59.
37. Huang S. Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2002; 2 : 469-76. (Pubitemid 37328944)
38. Daniel FI, Cherubini K, Yurgel LS, de Figueiredo MA, Salum FG. The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer 2011; 117 : 677-87.
39. Christman JK, Sheikhnejad G, Dizik M, Abileah S, Wainfan E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 1993; 14 : 551-7. (Pubitemid 23149981)
40. Eussen SJ, Vollset SE, Hustad S, et al. Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2010; 19 : 2549-61.
41. Figueiredo JC, Levine AJ, Grau MV, et al. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev 2008; 17 : 2136-45.
42. Lee JE, Li H, Giovannucci E, et al. Prospective study of plasma vitamin B6 and risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev 2009; 18 : 1197-202.
43. Weinstein SJ, Albanes D, Selhub J, et al. One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2008; 17 : 3233-40.
44. Le Marchand L, Wang H, Selhub J, Vogt TM, Yokochi L, Decker R. Association of plasma vitamin B6 with risk of colorectal adenoma in a multiethnic case-control study. Cancer Causes Control 2011; 22 : 929-36.
45. Lin J, Lee IM, Cook NR, et al. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr 2008; 87 : 734-43. (Pubitemid 351364556)
46. Wu K, Helzlsouer KJ, Comstock GW, Hoffman SC, Nadeau MR, Selhub J. A prospective study on folate, B12, and pyridoxal 5′- phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev 1999; 8 : 209-17. (Pubitemid 29114198)
47. Thurnham DI, Singkamani R, Situnayake RD, Davis M. Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma. Br Med J (Clin Res Ed) 1986; 293 : 695.